3Y Annualised Return
▲101.29%
5Y Annualised Return
▲74.54%
10Y Annualised Return
▲18.16%
Bacil Pharma Stock Performance
|
|
|
Bacil Pharma Company background
Founded in: 1987
Incorporated as a private limited company in Maharashtra in May 87, Bacil Pharma (BPL) was converted into a public limited company in Oct.90. The main business activity of the Company is Pharmaceutical.Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic OTC products, Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India. The company has strong field force of 500 plus, spread over various States and Districts. It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage. To augment the domestic market, Companys operations are based on focused approach.MultiSpeciality division Vibrant specialises in various specialties, like AntiInfectives, Pain Management, Respiratory Care, Womens Health, to name a few. Aziwin, Ebay, Balvibe, MNF, Ocium and Monogesic Plus Gel (Innovative Pain Relieving Gel, first time in India) are some of the leading brands in the respective segments. Bal Vedics Division integrates modern medicine with herbal/ayurvedic preparation targeting specific conditions like, Prostrate Enlargement, Renal Calculi, Male Infertility, Women Health etc. Bal Pharma Institutional division is associated with the top Government bodies and Hospitals to extend its product range to the masses. Every area is well covered and supplied through there channel partners.Bal Pharma Unit 1, is a finished dosage facility for manufacturing Tablets and Capsules. Bal Pharma Unit 2, is involved in the manufacturing of APIs. A wellequipped RD laboratory, a good Kilo laboratory and quality control facilities form the other spheres of activity here. Bal Pharma Unit 3, is a finished dosage facility for manufacturing Intravenous Fluids, Ophthalmic Preparations Liquid Oral Preparations. BPL came out with a public issue of Rs 7 cr in Mar.94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The company entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).
Bacil Pharma Share Price Today
As of 3 Dec 2025, Bacil Pharma share price is ₹40.9. The stock opened at ₹41.7 and had closed at ₹41.7 the previous day. During today’s trading session, Bacil Pharma share price moved between ₹39.59 and ₹43.09, with an average price for the day of ₹41.34. Over the last 52 weeks, the stock has recorded a low of ₹26.69 and a high of ₹62.56. In terms of performance, Bacil Pharma share price has declined by 1.5% over the past six months and has increased by 124.42% over the last year.
Bacil Pharma SIP Return Calculator
Over the past
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹30,93,337 in 5 years with a gain of ₹27,93,337 (+931.11%)
Bacil Pharma Fundamental
Market Cap (in crs)
58.76
Face Value
10
Turnover (in lacs)
5.84
Key Metrics
Qtr Change %
34.56% Fall from 52W High
16.8
Dividend yield 1yr %
0
Bacil Pharma Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
40.94
Current Price
Day EMA5
40.70
Day EMA10
39.30
Day EMA12
38.80
Day EMA20
37.80
Day EMA26
37.50
Day EMA50
37.80
Day EMA100
38.80
Day EMA200
37.40
Day SMA5
40.90
Day SMA10
39.60
Day SMA20
35.10
Day SMA30
35.90
Day SMA50
38.40
Day SMA100
38.80
Day SMA150
41.70
Day SMA200
42.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 12714 Rs | 14267 Rs |
Week Rs | 11807 Rs | 13798 Rs |
Month Rs | 20391 Rs | 23362 Rs |
Resistance & Support
41.21
Pivot
Resistance
First Resistance
42.82
Second Resistance
44.71
Third Resistance
46.32
Support
First Support
39.32
Second support
37.71
Third Support
35.82
Relative Strength Index
62.92
Money Flow Index
87.69
MACD
1.34
MACD Signal
0.30
Average True Range
3.07
Average Directional Index
29.42
Rate of Change (21)
24.70
Rate of Change (125)
-3.96
Bacil Pharma Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
33.57 | 54.62 | 32.6 | 68.53 | 35.85 | -10.07% | -15.63% | -30.90% | -49.40% | -39.95% | 0.00% | 19.03 | 41.70 | 2.56 | |
74.95 | 56.44 | 73.2 | 133.9 | 75.36 | -4.51% | -13.51% | -23.99% | -38.72% | 15.13% | 0.00% | 12.97 | 41.70 | 1.30 | |
197.50 | 62.77 | 162.2 | 330 | 197.65 | -6.46% | 16.07% | -5.05% | -31.41% | 43.12% | 1.01% | 13.86 | 41.70 | 1.60 | |
105.32 | 57.61 | 9.41 | 105.32 | 103.26 | 10.38% | 51.34% | 492.35% | 538.69% | 2,443.96% | 0.00% | 39.74 | 36.54 | 29.24 | |
38.10 | 62.23 | 35.7 | 69.7 | 37.45 | -5.41% | -8.19% | -2.01% | -29.09% | 0.00% | 0.00% | 8.60 | 41.70 | 1.07 | |
37.00 | 67.09 | 34.8 | 97.45 | 36.50 | -4.15% | -5.13% | -24.02% | -37.55% | 0.00% | 0.00% | 15.88 | 41.70 | 1.21 |
Bacil Pharma Share Price FAQs
How to buy Bacil Pharma shares?
You can easily buy Bacil Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Bacil Pharma ?
The 52-week high and low of Bacil Pharma share price is ₹62.56 and ₹26.69 as of 3/12/2025.
Please be aware that Bacil Pharma stock prices are subject to continuous fluctuations due to various factors.
Invest in Bacil Pharma